taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.
.
it shows that the longest waits for cancer treatment have soared since 2010.
.